| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Altimmune, Inc. (ALT) has 16 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. ALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 420.3K | $1.13M | - | |
| Other | 150.0K | $405.0K | - | |
| Other | 100.1K | $270.4K | - | |
| Other | 96.0K | $259.2K | - | |
| Dir | 48.8K | $131.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2017 | Gill John | Director | Buy | 1,000 | $4.34 | $4,343.50 | +1.2% | |
| Dec 9, 2016 | Prescott Group Capital Management, L.l.c. | 10% Owner | Sell | 1,354,632 | $3.26 | $4,411,695.53 | -6.0% | |
| Apr 13, 2016 | Richman Eric I79 | Director | Sale+OE | 329,354 | $2.20 | $724,578.80 | -31.8% | |
| Apr 8, 2016 | Richman Eric I79 | Director | Sale+OE | 11,767 | $2.20 | $25,887.40 | -3.2% | |
| Mar 19, 2015 | St Peter Steven | Director | Buy | 25,000 | $1.65 | $41,212.50 | New | |
| Jan 7, 2015 | Chang Linda L | SVP, CFO &Secretary | Sale+OE | 29,600 | $2.10 | $62,160.00 | -49.7% |